BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

550 related articles for article (PubMed ID: 29248586)

  • 21. Detection of Aspergillus DNA by a nested PCR assay is able to improve the diagnosis of invasive aspergillosis in paediatric patients.
    Hummel M; Spiess B; Roder J; von Komorowski G; Dürken M; Kentouche K; Laws HJ; Mörz H; Hehlmann R; Buchheidt D
    J Med Microbiol; 2009 Oct; 58(Pt 10):1291-1297. PubMed ID: 19541789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization and comparison of galactomannan enzyme immunoassay and quantitative real-time PCR assay for detection of Aspergillus fumigatus in bronchoalveolar lavage fluid from experimental invasive pulmonary aspergillosis.
    Francesconi A; Kasai M; Petraitiene R; Petraitis V; Kelaher AM; Schaufele R; Hope WW; Shea YR; Bacher J; Walsh TJ
    J Clin Microbiol; 2006 Jul; 44(7):2475-80. PubMed ID: 16825367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosing pulmonary aspergillosis in patients with hematological malignancies: a multicenter prospective evaluation of an Aspergillus PCR assay and a galactomannan ELISA in bronchoalveolar lavage samples.
    Reinwald M; Spiess B; Heinz WJ; Vehreschild JJ; Lass-Flörl C; Kiehl M; Schultheis B; Krause SW; Wolf HH; Bertz H; Maschmeyer G; Hofmann WK; Buchheidt D
    Eur J Haematol; 2012 Aug; 89(2):120-7. PubMed ID: 22650156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical evaluation of a polymerase chain reaction assay to detect Aspergillus species in bronchoalveolar lavage samples of neutropenic patients.
    Buchheidt D; Baust C; Skladny H; Baldus M; Bräuninger S; Hehlmann R
    Br J Haematol; 2002 Mar; 116(4):803-11. PubMed ID: 11886384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of PCR-ELISA and galactomannan detection for the diagnosis of invasive aspergillosis.
    Scotter JM; Campbell P; Anderson TP; Murdoch DR; Chambers ST; Patton WN
    Pathology; 2005 Jun; 37(3):246-53. PubMed ID: 16175901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical utility of Aspergillus galactomannan and PCR in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in patients with haematological malignancies.
    Heng SC; Chen SC; Morrissey CO; Thursky K; Manser RL; De Silva HD; Halliday CL; Seymour JF; Nation RL; Kong DC; Slavin MA
    Diagn Microbiol Infect Dis; 2014 Jul; 79(3):322-7. PubMed ID: 24768294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of PCR-ELISA and Real-Time PCR for invasive aspergillosis diagnosis in patients with hematological malignancies.
    Hadrich I; Mary C; Makni F; Elloumi M; Dumon H; Ayadi A; Ranque S
    Med Mycol; 2011 Jul; 49(5):489-94. PubMed ID: 21108574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosis of invasive aspergillosis by a commercial real-time PCR assay for Aspergillus DNA in bronchoalveolar lavage fluid samples from high-risk patients compared to a galactomannan enzyme immunoassay.
    Torelli R; Sanguinetti M; Moody A; Pagano L; Caira M; De Carolis E; Fuso L; De Pascale G; Bello G; Antonelli M; Fadda G; Posteraro B
    J Clin Microbiol; 2011 Dec; 49(12):4273-8. PubMed ID: 22012015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of clinical characteristics on the performance of galactomannan and PCR for the diagnosis of invasive aspergillosis in febrile neutropenic patients.
    Oz Y; Aslan M; Aksit F; Metintas S; Gunduz E
    Mycoses; 2016 Feb; 59(2):86-92. PubMed ID: 26627843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of Pneumocystis jirovecii and Aspergillus spp. DNa in bronchoalveolar lavage fluids by commercial real-time PCr assays: comparison with conventional diagnostic tests.
    Orsi CF; Bettua C; Pini P; Venturelli C; La Regina A; Morace G; Luppi M; Forghieri F; Bigliardi S; Luppi F; Codeluppi M; Girardis M; Blasi E
    New Microbiol; 2015 Jan; 38(1):75-84. PubMed ID: 25742150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients.
    Meersseman W; Lagrou K; Maertens J; Wilmer A; Hermans G; Vanderschueren S; Spriet I; Verbeken E; Van Wijngaerden E
    Am J Respir Crit Care Med; 2008 Jan; 177(1):27-34. PubMed ID: 17885264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of Aspergillus species in blood and bronchoalveolar lavage samples from immunocompromised patients by means of 2-step polymerase chain reaction: clinical results.
    Buchheidt D; Baust C; Skladny H; Ritter J; Suedhoff T; Baldus M; Seifarth W; Leib-Moesch C; Hehlmann R
    Clin Infect Dis; 2001 Aug; 33(4):428-35. PubMed ID: 11462176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Azole resistance in Aspergillus fumigatus from bronchoalveolar lavage fluid samples of patients with chronic diseases.
    Zhao Y; Stensvold CR; Perlin DS; Arendrup MC
    J Antimicrob Chemother; 2013 Jul; 68(7):1497-504. PubMed ID: 23463213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Performance of MycAssay Aspergillus DNA real-time PCR assay compared with the galactomannan detection assay for the diagnosis of invasive aspergillosis from serum samples.
    Danylo A; Courtemanche C; Pelletier R; Boudreault AA
    Med Mycol; 2014 Aug; 52(6):577-83. PubMed ID: 25023484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aspergillus galactomannan detection in exhaled breath condensate compared to bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in immunocompromised patients.
    Bhimji A; Bhaskaran A; Singer LG; Kumar D; Humar A; Pavan R; Lipton J; Kuruvilla J; Schuh A; Yee K; Minden MD; Schimmer A; Rotstein C; Keshavjee S; Mazzulli T; Husain S
    Clin Microbiol Infect; 2018 Jun; 24(6):640-645. PubMed ID: 28970160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evaluation of the lateral flow Aspergillus assay for the diagnosis of invasive aspergillosis, experience in a university hospital].
    Delama I; Legarraga P; González T; García P; Rabagliati R
    Rev Chilena Infectol; 2018; 35(5):574-579. PubMed ID: 30725006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aspergillus specific nested PCR from the site of infection is superior to testing concurrent blood samples in immunocompromised patients with suspected invasive aspergillosis.
    Boch T; Spiess B; Heinz W; Cornely OA; Schwerdtfeger R; Hahn J; Krause SW; Duerken M; Bertz H; Reuter S; Kiehl M; Claus B; Deckert PM; Hofmann WK; Buchheidt D; Reinwald M
    Mycoses; 2019 Nov; 62(11):1035-1042. PubMed ID: 31402465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The screening of blood by Aspergillus PCR and galactomannan ELISA precedes BAL detection in patients with proven and probable IA.
    Springer J; Löffler J; Einsele H; White PL
    Med Mycol; 2020 Aug; 58(6):856-858. PubMed ID: 32119062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective evaluation of a polymerase chain reaction-ELISA targeted to Aspergillus fumigatus and Aspergillus flavus for the early diagnosis of invasive aspergillosis in patients with hematological malignancies.
    Florent M; Katsahian S; Vekhoff A; Levy V; Rio B; Marie JP; Bouvet A; Cornet M
    J Infect Dis; 2006 Mar; 193(5):741-7. PubMed ID: 16453271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aspergillus-PCR in bronchoalveolar lavage for detection of invasive pulmonary aspergillosis in immunocompromised patients.
    Buess M; Cathomas G; Halter J; Junker L; Grendelmeier P; Tamm M; Stolz D
    BMC Infect Dis; 2012 Oct; 12():237. PubMed ID: 23031334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.